CN102066256A - 有序中孔氧化硅材料 - Google Patents

有序中孔氧化硅材料 Download PDF

Info

Publication number
CN102066256A
CN102066256A CN2009801244797A CN200980124479A CN102066256A CN 102066256 A CN102066256 A CN 102066256A CN 2009801244797 A CN2009801244797 A CN 2009801244797A CN 200980124479 A CN200980124479 A CN 200980124479A CN 102066256 A CN102066256 A CN 102066256A
Authority
CN
China
Prior art keywords
solution
range
buffer
ordered mesoporous
pore size
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2009801244797A
Other languages
English (en)
Chinese (zh)
Inventor
J·贾玛尔
A·阿尔茨
G·范登穆特
J·马藤松
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Formac Pharmaceuticals NV
Original Assignee
Formac Pharmaceuticals NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0807696A external-priority patent/GB0807696D0/en
Priority claimed from GB0903395A external-priority patent/GB0903395D0/en
Application filed by Formac Pharmaceuticals NV filed Critical Formac Pharmaceuticals NV
Publication of CN102066256A publication Critical patent/CN102066256A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B37/00—Compounds having molecular sieve properties but not having base-exchange properties
    • C01B37/02—Crystalline silica-polymorphs, e.g. silicalites dealuminated aluminosilicate zeolites
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/249921—Web or sheet containing structurally defined element or component
    • Y10T428/249953—Composite having voids in a component [e.g., porous, cellular, etc.]
    • Y10T428/249978—Voids specified as micro
    • Y10T428/249979—Specified thickness of void-containing component [absolute or relative] or numerical cell dimension

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Life Sciences & Earth Sciences (AREA)
  • Geology (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Silicon Compounds (AREA)
  • Steroid Compounds (AREA)
CN2009801244797A 2008-04-28 2009-04-28 有序中孔氧化硅材料 Pending CN102066256A (zh)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US12579508P 2008-04-28 2008-04-28
GB0807696.0 2008-04-28
US61/125,795 2008-04-28
GB0807696A GB0807696D0 (en) 2008-04-28 2008-04-28 Ordered mesoporous silica material
US13767308P 2008-08-01 2008-08-01
US61/137,673 2008-08-01
US20153208P 2008-12-11 2008-12-11
US61/201,532 2008-12-11
GB0903395A GB0903395D0 (en) 2009-02-27 2009-02-27 Ordered mesoporous silica material
GB0903395.2 2009-02-27
PCT/EP2009/055122 WO2009133100A2 (en) 2008-04-28 2009-04-28 Ordered mesoporous silica material

Publications (1)

Publication Number Publication Date
CN102066256A true CN102066256A (zh) 2011-05-18

Family

ID=41059555

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009801244797A Pending CN102066256A (zh) 2008-04-28 2009-04-28 有序中孔氧化硅材料

Country Status (10)

Country Link
US (1) US20110081416A1 (https=)
EP (1) EP2282973A2 (https=)
JP (1) JP5519639B2 (https=)
CN (1) CN102066256A (https=)
AU (1) AU2009242175B2 (https=)
BR (1) BRPI0910838A2 (https=)
CA (1) CA2721485C (https=)
MX (1) MX2010011670A (https=)
WO (1) WO2009133100A2 (https=)
ZA (1) ZA201007548B (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016041992A1 (en) 2014-09-15 2016-03-24 Grace Gmbh & Co. Kg Active-loaded particulate materials for topical administration
CN106456548A (zh) * 2014-03-31 2017-02-22 麻省理工学院 包括含药物活性物质化合物的多孔材料

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011110662A1 (en) * 2010-03-11 2011-09-15 Danmarks Tekniske Universitet Supported biologically active compounds
CN101823001B (zh) * 2010-04-29 2012-08-01 上海师范大学 氨基桥联有序介孔有机碱非均相催化剂的制备方法
WO2012025624A1 (en) 2010-08-27 2012-03-01 Formac Pharmaceuticals N.V. Processes for producing microporous silica materials
AU2011303849A1 (en) * 2010-09-14 2013-04-04 Nanologica Ab Super-saturating delivery vehicles for poorly water-soluble pharmaceutical and cosmetic active ingredients
US20130243833A1 (en) 2010-11-29 2013-09-19 Formac Pharmaceuticals N.V. Compressed formulations of ordered mesoporous silicas
PT2811829T (pt) * 2012-01-23 2019-02-25 Syngenta Ltd Processo para intensificação do crescimento de plantas
JP5652792B2 (ja) * 2012-04-27 2015-01-14 株式会社クラレ メソポーラスシリカの製造方法
ES2821528T3 (es) 2012-11-14 2021-04-26 Grace W R & Co Composiciones que contienen un material biológicamente activo y un óxido inorgánico no ordenado
WO2014148230A1 (ja) * 2013-03-19 2014-09-25 株式会社クラレ コーティング組成物及びそれを用いるメソポーラスシリカの製造方法
KR102695606B1 (ko) 2016-02-02 2024-08-14 유니버시티 오브 워싱턴 세라믹 선택적 막
AU2019205299B2 (en) 2018-01-04 2024-02-22 University Of Washington Nanoporous selective sol-gel ceramic membranes, selective -membrane structures, and related methods
EP3517500A1 (en) 2018-01-24 2019-07-31 Technische Universität Berlin A method for obtaining mesoporous silica particles with surface functionalisation
BR112021008732A2 (pt) 2018-11-07 2021-08-03 Disruptive Materials Pharma Ab ingredientes farmacêuticos amorfos ativos compreendendo carbonato de magnésio mesoporoso substancialmente amorfo
WO2020234675A1 (en) * 2019-04-30 2020-11-26 Vialpando, Llc Amorphous cannabinoid composition and processes of manufacture
EP3962457A4 (en) * 2019-04-30 2022-11-16 Vialpando, LLC CANNABINOID COMPOSITION AND PRODUCTION PROCESS THEREOF
CN111743685B (zh) * 2020-06-24 2022-07-15 天晴干细胞股份有限公司 一种医用冷敷贴
FR3122585A1 (fr) 2021-05-04 2022-11-11 Universite Claude Bernard Lyon 1 Solide mésoporeux pour réguler l’humidité dans les espaces clos
CN114920252A (zh) * 2022-06-28 2022-08-19 辽宁方诺生物科技有限公司 一类手性介孔二氧化硅纳米粒及其制备和应用
CN114988415B (zh) * 2022-07-01 2023-07-28 东北大学 一种硼酸辅助后处理制备介孔二氧化硅纳米粒子的方法
CN118270794B (zh) * 2024-04-22 2025-03-04 复旦大学 一种非晶二氧化硅二维材料及其制备方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1594079A (zh) * 2004-06-24 2005-03-16 华东理工大学 可用于纳米标准颗粒的纳米二氧化硅
CN1638738A (zh) * 2002-03-06 2005-07-13 根特大学 即释药物颗粒组合物及其连续制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6607705B2 (en) * 2000-04-13 2003-08-19 Board Of Trustees Of Michigan State University Process for the preparation of molecular sieve silicas
WO2003037511A1 (en) * 2001-11-01 2003-05-08 Silicycle Inc. Method of preparing highly ordered mesoporous molecular sieves
CN1247455C (zh) * 2002-12-30 2006-03-29 新加坡纳米材料科技有限公司 一种二氧化硅介孔材料及其制备方法
ES2247921B1 (es) * 2004-04-07 2007-06-16 Universidad Politecnica De Valencia Un material amorfo microporoso, procedimiento de preparacion y su uso en la conversion catalitica de compuestos organicos.
GB0420016D0 (en) * 2004-09-09 2004-10-13 Leuven K U Res & Dev Controlled release oral delivery system

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1638738A (zh) * 2002-03-06 2005-07-13 根特大学 即释药物颗粒组合物及其连续制备方法
CN1594079A (zh) * 2004-06-24 2005-03-16 华东理工大学 可用于纳米标准颗粒的纳米二氧化硅

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JIAN LIU ET AL: "Pore size control of mesoporous silicas from mixtures of sodium silicate and TEOS", 《MICROPOROUS AND MESOPOROUS MATERIALS》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106456548A (zh) * 2014-03-31 2017-02-22 麻省理工学院 包括含药物活性物质化合物的多孔材料
WO2016041992A1 (en) 2014-09-15 2016-03-24 Grace Gmbh & Co. Kg Active-loaded particulate materials for topical administration

Also Published As

Publication number Publication date
CA2721485C (en) 2013-12-24
EP2282973A2 (en) 2011-02-16
CA2721485A1 (en) 2009-11-05
BRPI0910838A2 (pt) 2017-05-30
US20110081416A1 (en) 2011-04-07
ZA201007548B (en) 2011-07-27
AU2009242175B2 (en) 2013-02-07
AU2009242175A1 (en) 2009-11-05
WO2009133100A2 (en) 2009-11-05
JP2011518756A (ja) 2011-06-30
JP5519639B2 (ja) 2014-06-11
MX2010011670A (es) 2011-05-02
WO2009133100A3 (en) 2009-12-23

Similar Documents

Publication Publication Date Title
CN102066256A (zh) 有序中孔氧化硅材料
KR102371097B1 (ko) 무기성 코팅을 갖는 고형의 나노입자
US8246999B2 (en) Capped mesoporous silicates
Vilaça et al. Potentiation of 5-fluorouracil encapsulated in zeolites as drug delivery systems for in vitro models of colorectal carcinoma
JP2011515444A (ja) 固体分散体の調製方法
HK1210048A1 (en) Bioerodible silicon-based devices for delivery of therapeutic agents
JP2021143177A (ja) 生理活性物質送達体
JP5848326B2 (ja) ペクチン−アドリアマイシン共役体の凍結乾燥製剤および製造方法
JP2003026607A (ja) 薬剤と濃度を高めるポリマーとを含む医薬組成物
Qiu et al. Lipid-coated hollow mesoporous silica nanospheres for co-delivery of doxorubicin and paclitaxel: preparation, sustained release, cellular uptake and pharmacokinetics
Li et al. Biomimetic synthesis and evaluation of histidine-derivative templated chiral mesoporous silica for improved oral delivery of the poorly water-soluble drug, nimodipine
JP2011225380A (ja) メソポーラスシリカ材料の製造方法
CN105560186A (zh) 一种治疗心脏病的缓释药物制剂
RU2476377C2 (ru) Упорядоченный мезопористый кремнийоксидный материал
CN106456548A (zh) 包括含药物活性物质化合物的多孔材料
Cao et al. Influence of adsorption state and molecular interaction on physical stability of confined amorphous vortioxetine
Kim et al. Amine-grafted SBA-15 for ophthalmic delivery of dexamethasone
WO2012025624A1 (en) Processes for producing microporous silica materials
Mahajan Development of Mesoporous Silica Nanoparticles for Bioavailability Enhancement of Some Anti Hiv Drugs
CN117982447A (zh) 一种载药的纳米空心炭球及其制备方法和应用
EP3989942A1 (en) Mesoporous polymeric particulate material
HK1188733A (en) Bioerodible silicon-based devices for delivery of therapeutic agents
Patra et al. Porous carriers in drug delivery systems
CN102793662A (zh) 一种普罗布考纳米混悬液及其制备方法
Doadrio Villarejo et al. Drug Release from Ordered Mesoporous Silicas

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C05 Deemed withdrawal (patent law before 1993)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20110518